Doskaliuk, Bohdana; Ravichandran, Naveen 
; Sen, Parikshit ; Day, Jessica ; Joshi, Mrudula; Nune, Arvind; Nikiphorou, Elena ; Saha, Sreoshy ; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: VACINAÇÃO, COVID-19, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOSKALIUK, Bohdana et al. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, v. 43, n. 9, p. 1651-1664, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55968. Acesso em: 09 jul. 2024.APA
Doskaliuk, B., Ravichandran, N., Sen, P., Day, J., Joshi, M., Nune, A., et al. (2023). Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, 43( 9), 1651-1664. doi:10.1007/s00296-023-05345-yNLM
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2024 jul. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968Vancouver
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2024 jul. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
